Psychedelics might be the future for mental health care

Credit: Unsplash+

Psychedelics – you’ve probably heard of them mostly as party drugs. But did you know these ‘trippy’ substances might be game-changers for mental health treatment?

Dr. Jennifer Jones, a researcher from the Medical University of South Carolina, is really excited about the potential of psychedelics in psychiatry. She calls them “catalysts for change.”

Ecstasy: From Party Drug to Therapeutic Game-Changer

One of these psychedelic substances, MDMA (better known as “ecstasy”), could soon be approved to treat post-traumatic stress disorder (PTSD).

If approved by the Food and Drug Administration (FDA), it would be the first psychedelic substance used officially for treatment, which is pretty revolutionary!

Reaching Those Hard-to-Reach Patients

While we have some good treatments for PTSD, they don’t work for everyone. For people who struggle with both PTSD and substance use disorder (SUD), the current treatments can be less effective.

That’s why Dr. Jones thinks psychedelics could make a real difference, especially for this group.

The Colorful History of Psychedelics

Psychedelics are a group of drugs that have been around for centuries. They can be natural, like psilocybin (magic mushrooms), or synthetic, like LSD and MDMA.

They were mostly studied in the 1950s and 1960s. But it was only recently that researchers started noticing how these drugs can help with mental health disorders, such as PTSD, depression, and SUD.

The Versatile Power of MDMA

Around 80 clinical trials involving MDMA have been conducted or are ongoing since 2009.

These trials are looking at how MDMA can help with various disorders, including anxiety, depression, obsessive-compulsive disorder, SUD, and PTSD.

In MDMA-assisted therapy, the drug is used along with “talk therapy”.

The idea is that MDMA helps to reduce fear related to traumatic memories, helping the patient to better process these memories. And this can lead to improvement in other disorders, like SUD.

The Challenge: Facing Stigma and Misconceptions

The main hurdle is the stigma attached to psychedelics. They’re often seen as harmful drugs with no medical benefits.

This can make people hesitant to try psychedelic-based treatments. Dr. Jones’ recent study looked at people’s attitudes towards these treatments.

Turning the Tide: Positive Views on MDMA-Assisted Therapy

In her study, Dr. Jones found that about 70% of people are supportive of MDMA research and believe that it could be helpful for mental health.

And 59% said they would be willing to try MDMA-assisted therapy if a health professional recommended it.

Interestingly, people from different racial and ethnic groups showed similar levels of support for MDMA research.

However, their willingness to try MDMA-assisted therapy varied, which might be due to cultural beliefs or past experiences.

Making Psychedelic Therapy Accessible to All

Dr. Jones hopes that these findings can help make psychedelic treatments more accessible to all. She believes it’s crucial to address people’s concerns and stigma about these treatments.

“My heartfelt goal is that everyone who might benefit from MDMA-assisted therapy can receive treatment once it is available,” she says.

So, while psychedelics might sound like an unusual tool for mental health treatment, they’re showing great promise. As we learn more, they might just be the magic pills we need to revolutionize mental health care!

If you care about mental health, please read studies about scientists find a core feature of depression and this metal in the brain strongly linked to depression.

For more information about mental health, please see recent studies about drug for mental health that may harm the brain, and results showing this therapy more effective than ketamine in treating severe depression.

The study was published in Frontiers in Psychiatry.

Follow us on Twitter for more articles about this topic.

Copyright © 2023 Knowridge Science Report. All rights reserved.